These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32921794)

  • 21. Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes.
    Modinos G; Richter A; Egerton A; Bonoldi I; Azis M; Antoniades M; Bossong M; Crossley N; Perez J; Stone JM; Veronese M; Zelaya F; Grace AA; Howes OD; Allen P; McGuire P
    Neuropsychopharmacology; 2021 Jul; 46(8):1468-1474. PubMed ID: 33941857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis.
    Livingston NR; Kiemes A; Devenyi GA; Knight S; Lukow PB; Jelen LA; Reilly T; Dima A; Nettis MA; Casetta C; Agyekum T; Zelaya F; Spencer T; De Micheli A; Fusar-Poli P; Grace AA; Williams SCR; McGuire P; Egerton A; Chakravarty MM; Modinos G
    Neuropsychopharmacology; 2024 Aug; 49(9):1448-1458. PubMed ID: 38658738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Thermenos HW; Juelich RJ; DiChiara SR; Mesholam-Gately RI; Woodberry KA; Wojcik J; Makris N; Keshavan MS; Whitfield-Gabrieli S; Woo TU; Petryshen TL; Goldstein JM; Shenton ME; McCarley RW; Seidman LJ
    Schizophr Res; 2016 May; 173(1-2):1-12. PubMed ID: 26965745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.
    Kindler J; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Walther S; Schimmelmann BG; Hubl D
    Schizophr Bull; 2018 Jan; 44(1):182-192. PubMed ID: 28575528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis.
    Du Y; Fryer SL; Fu Z; Lin D; Sui J; Chen J; Damaraju E; Mennigen E; Stuart B; Loewy RL; Mathalon DH; Calhoun VD
    Neuroimage; 2018 Oct; 180(Pt B):632-645. PubMed ID: 29038030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis.
    Schmidt A; Davies C; Paloyelis Y; Meyer N; De Micheli A; Ramella-Cravaro V; Provenzani U; Aoki Y; Rutigliano G; Cappucciati M; Oliver D; Murguia S; Zelaya F; Allen P; Shergill S; Morrison P; Williams S; Taylor D; Borgwardt S; Yamasue H; McGuire P; Fusar-Poli P
    Transl Psychiatry; 2020 Jun; 10(1):203. PubMed ID: 32572020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder.
    van Boxel R; Gangadin SS; Janssen H; van der Steur S; van der Vinne LJC; Dortants L; Pelgrim TAD; Draisma LWR; Tuura R; van der Meer P; Batalla A; Bossong MG
    J Psychiatr Res; 2023 Jul; 163():93-101. PubMed ID: 37207437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring neural dysfunction in 'clinical high risk' for psychosis: a quantitative review of fMRI studies.
    Dutt A; Tseng HH; Fonville L; Drakesmith M; Su L; Evans J; Zammit S; Jones D; Lewis G; David AS
    J Psychiatr Res; 2015 Feb; 61():122-34. PubMed ID: 25479766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probabilistic Category Learning and Striatal Functional Activation in Psychosis Risk.
    Karcher NR; Hua JPY; Kerns JG
    Schizophr Bull; 2019 Mar; 45(2):396-404. PubMed ID: 29590478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatum-related functional activation during reward- versus punishment-based learning in psychosis risk.
    Karcher NR; Hua JPY; Kerns JG
    Neuropsychopharmacology; 2019 Oct; 44(11):1967-1974. PubMed ID: 31272104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cannabidiol (CBD) on regional cerebral blood flow.
    Crippa JA; Zuardi AW; Garrido GE; Wichert-Ana L; Guarnieri R; Ferrari L; Azevedo-Marques PM; Hallak JE; McGuire PK; Filho Busatto G
    Neuropsychopharmacology; 2004 Feb; 29(2):417-26. PubMed ID: 14583744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
    Allendorfer JB; Nenert R; Bebin EM; Gaston TE; Grayson LE; Hernando KA; Houston JT; Hansen B; Szaflarski JP
    Epilepsy Behav; 2019 Jul; 96():114-121. PubMed ID: 31129526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Lemmers-Jansen ILJ; Fett AJ; Hanssen E; Veltman DJ; Krabbendam L
    Psychol Med; 2019 Apr; 49(5):780-790. PubMed ID: 29897026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people.
    Rawlings NB; Norbury R; Cowen PJ; Harmer CJ
    Psychopharmacology (Berl); 2010 Dec; 212(4):625-34. PubMed ID: 20809213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Assessment and Functional Neuroimaging of Movement Variability Reveal Novel Insights Into Motor Dysfunction in Clinical High Risk for Psychosis.
    Dean DJ; Bernard JA; Damme KSF; O'Reilly R; Orr JM; Mittal VA
    Schizophr Bull; 2020 Dec; 46(6):1567-1576. PubMed ID: 32662507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.
    Borgwardt SJ; Allen P; Bhattacharyya S; Fusar-Poli P; Crippa JA; Seal ML; Fraccaro V; Atakan Z; Martin-Santos R; O'Carroll C; Rubia K; McGuire PK
    Biol Psychiatry; 2008 Dec; 64(11):966-73. PubMed ID: 18589404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesion side matters - an fMRI study on the association between neural correlates of watching dynamic fearful faces and their evaluation in patients with temporal lobe epilepsy.
    Labudda K; Mertens M; Steinkroeger C; Bien CG; Woermann FG
    Epilepsy Behav; 2014 Feb; 31():321-8. PubMed ID: 24210457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of working memory and emotion in persons clinically at risk for psychosis: an fMRI pilot study.
    Pauly K; Seiferth NY; Kellermann T; Ruhrmann S; Daumann B; Backes V; Klosterkötter J; Shah NJ; Schneider F; Kircher TT; Habel U
    Schizophr Res; 2010 Jul; 120(1-3):167-76. PubMed ID: 20053536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Cannabidiol on Human Brain Function: A Systematic Review.
    Batalla A; Bos J; Postma A; Bossong MG
    Front Pharmacol; 2020; 11():618184. PubMed ID: 33551817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.